TOLEJI Trademark

Trademark Overview

On Thursday, October 20, 2016, a trademark application was filed for TOLEJI with the United States Patent and Trademark Office. The USPTO has given the TOLEJI trademark a serial number of 87210163. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, April 7, 2020. This trademark is owned by Pfizer Inc.. The TOLEJI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
toleji

General Information

Serial Number87210163
Word MarkTOLEJI
Filing DateThursday, October 20, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, April 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 26, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, June 5, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, June 5, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2019EXTENSION 5 GRANTED
Tuesday, September 10, 2019EXTENSION 5 FILED
Friday, September 13, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 10, 2019TEAS EXTENSION RECEIVED
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019EXTENSION 4 GRANTED
Friday, March 8, 2019EXTENSION 4 FILED
Friday, March 8, 2019TEAS EXTENSION RECEIVED
Wednesday, September 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 17, 2018EXTENSION 3 GRANTED
Monday, September 17, 2018EXTENSION 3 FILED
Monday, September 17, 2018TEAS EXTENSION RECEIVED
Friday, March 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 7, 2018EXTENSION 2 GRANTED
Wednesday, March 7, 2018EXTENSION 2 FILED
Wednesday, March 7, 2018TEAS EXTENSION RECEIVED
Saturday, September 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2017EXTENSION 1 GRANTED
Thursday, September 14, 2017EXTENSION 1 FILED
Thursday, September 14, 2017TEAS EXTENSION RECEIVED
Tuesday, April 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 27, 2016ASSIGNED TO EXAMINER
Wednesday, October 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 24, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

toleji preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases